Acquiring Company
ClinChoice
Acquired Company
CSI Medical Research
Fort Washington
SingaporePharmaceutical ManufacturingPharmaceutical ManufacturingDescription
ClinChoice, a leading global Contract Research Organization (CRO), has expanded its global footprint into Southeast Asia and Australia/New Zealand through the acquisition of CSI Medical Research. With this strategic acquisition, ClinChoice further broadens its full-service capabilities and enhances its presence in the region to meet the increasing demand for clinical research and drug development trials.
Quick answer
ClinChoice is acquiring CSI Medical Research, announced January 12, 2024. ClinChoice is based in Fort Washington, Pennsylvania, United States.
- How much did ClinChoice pay for CSI Medical Research?
- The deal value was not disclosed.
- What does ClinChoice do?
- ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide.
- Where are ClinChoice and CSI Medical Research based?
- ClinChoice is based in Fort Washington, Pennsylvania, United States. CSI Medical Research is based in Singapore, Southeast Asia, Singapore.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical Manufacturing and Pharmaceutical Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Merck Animal Health to Acquire Elanco’s Aqua Business (February 5, 2024)
- Polaris Group Announced The Acquisition Of Genovior Biotech, Initiating Dual-Engine Growth (December 22, 2023)
- Astellas Completes Acquisition Of Propella Therapeutics (December 21, 2023)
- Aurora Cannabis Acquires MedReleaf Australia (February 8, 2024)
- Spectrum Science Acquires Continuum Clinical, Amplifying Patient Recruitment Capabilities (February 8, 2024)
- Curaleaf International Acquires Can4Med, Expanding Presence in Poland's Growing Medical Cannabis Market (February 6, 2024)
Who to call at ClinChoice, and when
When ClinChoice changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ClinChoice raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ClinChoice, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ClinChoice. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ClinChoice makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired CSI Medical Research?
CSI Medical Research was acquired by ClinChoice, based in Fort Washington. The deal was reported on January 12, 2024. ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. ClinChoice is privately held and operates in Pharmaceutical Manufacturing.
When did ClinChoice acquire CSI Medical Research?
ClinChoice's acquisition of CSI Medical Research was reported on January 12, 2024. ClinChoice, a leading global Contract Research Organization (CRO), has expanded its global footprint into Southeast Asia and Australia/New Zealand through the acquisition of CSI Medical Research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CSI Medical Research do?
We are a home grown, Singapore based and registered Clinical Research Organisation (CRO) with intent to provide clinical trials related service offerings to our customers. It is privately held, operating in Pharmaceutical Manufacturing, and is based in Singapore.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.